Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

GlobeNewswireAug 28, 2023 20:00

Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases

GlobeNewswireJun 21, 2023 20:00

Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing

GlobeNewswireJun 5, 2023 22:00

Short Interest in Innovation Pharmaceuticals Inc. (OTCMKTS:IPIX) Expands By 30.3%

kopsourceApr 20, 2023 04:43

Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

GlobeNewswireApr 17, 2023 20:05

Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers

GlobeNewswireMar 15, 2023 20:03